Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?
Mary K. Herrick, Malú G. Tansey
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 69

Showing 26-50 of 69 citing articles:

Fecal Calprotectin in Parkinson’s Disease and Multiple System Atrophy
Jia Wei Hor, Shen‐Yang Lim, Eng-Soon Khor, et al.
Journal of Movement Disorders (2021) Vol. 15, Iss. 2, pp. 106-114
Open Access | Times Cited: 25
The link between the gut microbiome, inflammation, and Parkinson’s disease
Shiqing Nie, Yuan Ge
Applied Microbiology and Biotechnology (2023) Vol. 107, Iss. 22, pp. 6737-6749
Closed Access | Times Cited: 9
Interactions between gut microbiota and Parkinson's disease: The role of microbiota-derived amino acid metabolism
Wang Wang, Shujun Jiang, Chengcheng Xu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 16
Inflammatory bowel disease and risk of dementia: An updated meta-analysis
Nanyang Liu, Yi Wang, Lanye He, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 15
LRRK2: Genetic mechanisms vs genetic subtypes
Ignácio F. Mata, Philippe A. Salles, Mario Cornejo‐Olivas, et al.
Handbook of clinical neurology (2023), pp. 133-154
Closed Access | Times Cited: 9
Immunological Features of LRRK2 Function and Its Role in the Gut-Brain Axis Governing Parkinson’s Disease
Inga Peter, Warren Strober
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 3, pp. 279-296
Open Access | Times Cited: 9
ASO-mediated knockdown or kinase inhibition of G2019S-Lrrk2 modulates lysosomal tubule-associated antigen presentation in macrophages
Rebecca L. Wallings, Julian R Mark, Hannah A. Staley, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 34, pp. 102064-102064
Open Access | Times Cited: 8
LRRK2 signaling in neurodegeneration: two decades of progress
Lucia Iannotta, Elisa Greggio
Essays in Biochemistry (2021) Vol. 65, Iss. 7, pp. 859-872
Closed Access | Times Cited: 18
Effects of ulcerative colitis and Crohn’s disease on neurodegenerative diseases: A Mendelian randomization study
Hong Li, Zheng Wen
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 14
Genetic overlap between Parkinson’s disease and inflammatory bowel disease
Xiaoying Kang, Alexander Ploner, Yunzhang Wang, et al.
Brain Communications (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 13
Transforming Parkinson's Care in Africa (TraPCAf): protocol for a multimethodology National Institute for Health and Care Research Global Health Research Group project
Richard Walker, Natasha Fothergill‐Misbah, Samuel Kariuki, et al.
BMC Neurology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Role of the Gut Microbiome and Bacterial Amyloids in the Development of Synucleinopathies
Nina P. Trubitsina, Anton B. Matiiv, Tatyana Rogoza, et al.
Biochemistry (Moscow) (2024) Vol. 89, Iss. 3, pp. 523-542
Closed Access | Times Cited: 2
Bidirectional communication of the gut-brain axis: new findings in Parkinson’s disease and inflammatory bowel disease
Wanyi Zhang, Yan Jiao, Huang Wen, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 2
The R1441C-Lrrk2 mutation induces myeloid immune cell exhaustion in an age- and sex-dependent manner in mice
Rebecca L. Wallings, Karen N. McFarland, Hannah A. Staley, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 772
Open Access | Times Cited: 2
New Perspectives on Immune Involvement in Parkinson’s Disease Pathogenesis
David Gate
Journal of Parkinson s Disease (2022) Vol. 12, Iss. s1, pp. S5-S11
Open Access | Times Cited: 10
Structural Insights and Development of LRRK2 Inhibitors for Parkinson’s Disease in the Last Decade
Gunjan Thakur, Vikas Kumar, Keun Woo Lee, et al.
Genes (2022) Vol. 13, Iss. 8, pp. 1426-1426
Open Access | Times Cited: 10
The relationship between Central Nervous System morphometry changes and key symptoms in Crohn’s disease
Gita Thapaliya, Sally Eldeghaidy, Michael Asghar, et al.
Brain Imaging and Behavior (2022) Vol. 17, Iss. 2, pp. 149-160
Open Access | Times Cited: 10
Regional genetic correlations highlight relationships between neurodegenerative disease loci and the immune system
Frida Lona‐Durazo, Regina H. Reynolds, Sonja W. Scholz, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 6
The Interface between Inflammatory Bowel Disease, Neuroinflammation, and Neurological Disorders
Grace Hey, Vinata Vedam‐Mai, Matthew Beke, et al.
Seminars in Neurology (2023) Vol. 43, Iss. 04, pp. 572-582
Closed Access | Times Cited: 5
Mice with the Rab10 T73V mutation exhibit anxiety-like behavior and alteration of neuronal functions in the striatum
Jing Zhang, Jie Li, Pan You, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 4, pp. 166641-166641
Open Access | Times Cited: 4
Association between Inflammatory Bowel Disease and Subsequent Development of Restless Legs Syndrome and Parkinson’s Disease: A Retrospective Cohort Study of 35,988 Primary Care Patients in Germany
Sven H. Loosen, Kaneschka Yaqubi, Petra May, et al.
Life (2023) Vol. 13, Iss. 4, pp. 897-897
Open Access | Times Cited: 4
Parkinson’s VPS35[D620N] mutation induces LRRK2 mediated lysosomal association of RILPL1 and TMEM55B
Prosenjit Pal, Matthew Taylor, Yuko P. Y. Lam, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
LRRK2 is involved in heat exposure-induced acute lung injury and alveolar type II epithelial cell dysfunction
Yindan Wang, Wenjun Fan, Guoqing Zhang, et al.
Environmental Pollution (2024) Vol. 347, pp. 123643-123643
Open Access | Times Cited: 1
Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson’s disease: a patent review of the literature to date
Margaux Morez, Antonio Jesús Lara Ordóñez, Patricia Melnyk, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 9, pp. 773-788
Closed Access | Times Cited: 1
Peripheral Blood Immune Cells from Individuals with Parkinson's Disease or Inflammatory Bowel Disease Share Deficits in Iron Storage and Transport that are Modulated by Non-Steroidal Anti-Inflammatory Drugs
MacKenzie L. Bolen, Beatriz Maffini Gomes, B. Gill, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Scroll to top